Insulet officer granted 1,808 shares; 622 withheld
Insulet Corporation executive Lauren Budden reported equity compensation activity involving company common stock.
Rhea-AI Filing Summary
Insulet Corporation executive Lauren Budden reported equity compensation activity involving company common stock. On February 12, 2026, Budden acquired 1,808 shares of Insulet common stock at $0 per share through the settlement of performance share units that vested based on performance criteria.
Upon completion of these awards, 622 shares were withheld at a price of $240.82 per share to cover related tax obligations, a non‑market, tax-withholding disposition. After these transactions, Budden directly beneficially owned 8,188 shares of Insulet common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,808 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 622 | $240.82 | $150K |
Footnotes (3)
- F1. Represents shares issued upon the satisfaction of performance criteria related to Performance Share Units ("PSUs"). The PSUs were settled in shares of common stock on a one-for-one basis.
- F2. Includes 86 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 filing.
- F3. This transaction represents the withholding of shares upon the vesting of PSUs to cover the associated tax obligations.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did PODD executive Lauren Budden report on February 12, 2026?
What role does Lauren Budden hold at Insulet (PODD) according to this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.